San Marcos, CA, United States of America

Pierre-Yves Michellys

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 7.3

ph-index = 7

Forward Citations = 141(Granted Patents)


Location History:

  • San Marcos, CA (US) (2010 - 2016)
  • San Diego, CA (US) (2002 - 2021)

Company Filing History:


Years Active: 2002-2021

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: Pierre-Yves Michellys: Innovator in Pharmaceutical Compounds

Introduction

Pierre-Yves Michellys is a distinguished inventor based in San Marcos, California. With a remarkable portfolio of 18 patents, Michellys has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds designed to address various health conditions.

Latest Patents

Michellys' most recent patents focus on innovative compounds and compositions. His first patent, "Compounds and compositions as inhibitors of endosomal toll-like receptors," involves 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridinyl compounds and related formulations. This invention aims to contribute to the treatment of autoimmune diseases through pharmaceutical compositions derived from these compounds.

Another notable patent is "Compounds and compositions for modulating EGFR Activity." This invention offers compounds and pharmaceutical compositions intended to modulate EGFR activity, which is crucial in treating conditions related to abnormal or deregulated EGFR activity.

Career Highlights

Throughout his career, Michellys has worked with several organizations contributing to his innovative advancements in pharmaceuticals. Notably, he has been associated with Irm LLC, where his research and development efforts have paved the way for numerous breakthroughs in therapeutic applications.

Collaborations

Collaboration has played a pivotal role in Michellys' success as an inventor. He has partnered with esteemed colleagues such as Wei Pei and Thomas H. Marsilje III. Together, they have driven forward the mission of developing effective treatments through cutting-edge research.

Conclusion

In summary, Pierre-Yves Michellys stands out as a prolific inventor with a focus on creating pharmaceutical compounds that address critical healthcare needs. His recent patents exemplify his commitment to innovation in the treatment of autoimmune diseases and EGFR-related conditions, making a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…